Introducing WHO

Practical challenges of introducing WHO surgical checklist: UK pilot experience.

Introducing vedolizumab to clinical practice: who, when, and how?

Vedolizumab (VDZ), a humanized monoclonal antibody that selectively targets α4β7 integrin, is approved for use in inflammatory bowel disease (IBD). Here we review the evidence for the safety and efficacy of VDZ in IBD, in order to identify patients likely to benefit from therapy and to integrate VDZ into clinical practice. A bibliographic search was performed of the online databases MEDLINE, EM...

Acceptability and Feasibility of Introducing the WHO Focused Antenatal Care Package in Ghana

The opinions expressed herein are those of the authors and do not necessarily reflect the views of USAID. Acknowledgements We gratefully acknowledge the invaluable support received from the Director of the Noguchi Memorial Institute for Medical Research, Prof. David Ofori-Adjei, during the planning and implementation of this project. We also wish to acknowledge the substantial contributions mad...

Introducing TRIM

We present TRIM, an abstract machine capable of executing a subset of the algebraic speci cation language OBJ3. A speci cally designed compiler translates the order sorted conditional equations of an OBJ3 speci cation into TRIM code. The fact that TRIM supports order sorted term rewriting natively di erentiates it from many other abstract term rewriting machines. To obtain more e cient abstract...

Introducing, OncoTarget

Previous decades have witnessed intensive accumulation of knowledge on oncogenes, oncoproteins, tumor suppressors, signal transduction, cellular processes (such as proliferation, differentiation, apoptosis, autophagy, migration), cellular responses (such as DNA damage, heat shock responses), intercellular interactions (cell-cell communications), and the function and dysfunction of cells and org...